Key facts
- Keragon’s last known valuation is $32.0M (Feb 2025).
- It has raised $10.5M; the latest was Seed Round ($7.5M) in Feb 2025.
- Notable investors include Afore Capital, Upfront Ventures, Endeavor Greece, 25madison, Focal (VC) — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Keragon
- ·The full record, as it builds
Funding rounds
No funding rounds for Keragon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Keragon
Operator of a healthcare integration and automation platform intended to simplify and automate healthcare workflows. The company allows healthcare organizations to connect their disparate systems and automate common tasks, such as appointment scheduling, healthcare customer relation management, AI medical scribes, patient intake, and billing, enabling healthcare product teams to improve efficiency, reduce costs, and improve patient care.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2022
- Employees
- 22
- Website
- keragon.com/
- Ownership
- Privately Held (backing)
Keragon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Keragon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Keragon in its N-PORT filings yet. We sweep new filings monthly.